CA2349733A1 - Inhibition de resorption osseuse - Google Patents

Inhibition de resorption osseuse Download PDF

Info

Publication number
CA2349733A1
CA2349733A1 CA002349733A CA2349733A CA2349733A1 CA 2349733 A1 CA2349733 A1 CA 2349733A1 CA 002349733 A CA002349733 A CA 002349733A CA 2349733 A CA2349733 A CA 2349733A CA 2349733 A1 CA2349733 A1 CA 2349733A1
Authority
CA
Canada
Prior art keywords
alendronate
dosing
administered
bisphosphonate
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002349733A
Other languages
English (en)
Inventor
Anastasia G. Daifotis
Arthur C. Ii Santora
A. John Yates
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck & Co., Inc.
Anastasia G. Daifotis
Arthur C. Ii Santora
A. John Yates
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9717590.5A external-priority patent/GB9717590D0/en
Priority claimed from GBGB9717850.3A external-priority patent/GB9717850D0/en
Application filed by Merck & Co., Inc., Anastasia G. Daifotis, Arthur C. Ii Santora, A. John Yates filed Critical Merck & Co., Inc.
Priority claimed from CA002294595A external-priority patent/CA2294595C/fr
Publication of CA2349733A1 publication Critical patent/CA2349733A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002349733A 1997-07-22 1998-07-17 Inhibition de resorption osseuse Abandoned CA2349733A1 (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US5335197P 1997-07-22 1997-07-22
US60/053,351 1997-07-22
US5353597P 1997-07-23 1997-07-23
US60/053,535 1997-07-23
GB9717590.5 1997-08-20
GBGB9717590.5A GB9717590D0 (en) 1997-08-20 1997-08-20 Oral method for treating or preventing abnormal bone resorption
GBGB9717850.3A GB9717850D0 (en) 1997-08-22 1997-08-22 Oral method for treating or preventing abnormal bone resorption
GB9717850.3 1997-08-22
CA002294595A CA2294595C (fr) 1997-07-22 1998-07-17 Inhibition de resorption osseuse

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002294595A Division CA2294595C (fr) 1997-07-22 1998-07-17 Inhibition de resorption osseuse

Publications (1)

Publication Number Publication Date
CA2349733A1 true CA2349733A1 (fr) 1999-02-04

Family

ID=27508711

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002349744A Abandoned CA2349744A1 (fr) 1997-07-22 1998-07-17 Inhibition de resorption osseuse
CA002349733A Abandoned CA2349733A1 (fr) 1997-07-22 1998-07-17 Inhibition de resorption osseuse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002349744A Abandoned CA2349744A1 (fr) 1997-07-22 1998-07-17 Inhibition de resorption osseuse

Country Status (1)

Country Link
CA (2) CA2349744A1 (fr)

Also Published As

Publication number Publication date
CA2349744A1 (fr) 1999-02-04

Similar Documents

Publication Publication Date Title
US5994329A (en) Method for inhibiting bone resorption
US6015801A (en) Method for inhibiting bone resorption
US6465443B2 (en) Method for inhibiting bone resorption
CA2294595C (fr) Inhibition de resorption osseuse
GB2336311A (en) Bisphosphonate Dosing Regimen
AU741818B2 (en) Method for inhibiting bone resorption
CA2349733A1 (fr) Inhibition de resorption osseuse
AU2007211965B2 (en) Alendronate for use in the treatment of osteoporosis
AU2451102A (en) Method for inhibiting bone resorption
AU1567702A (en) Method for inhibiting bone resorption
IL153109A (en) An effective pharmaceutical composition for inhibiting bone resorption in humans containing alendronic acid or its acceptable pharmaceutical salt or mixture
AU2005227418A1 (en) Method for inhibiting bone resorption
MXPA00000789A (en) Method for inhibiting bone resorption
HRP20000035A2 (en) Method for inhibiting bone resorption

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead